- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
AstraZeneca Pharma India reported 30% revenue growth to ₹682.8 Cr, with ₹51 Cr profit before tax. Performance was driven by core therapy areas. The company strengthened its portfolio with key regulatory approvals and strategic initiatives like the Telangana AI-enabled lung cancer screening MoU.